Mesoblast | MSB - Equity Capital And Reserves



Mesoblast reported 480.35M in Equity Capital and Reserves for its fiscal semester ending in June of 2024.


Equity Capital And Reserves Change Date
Avita Medical AUD 4.5M 19.42M Dec/2024
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Cochlear AUD 1.87B 27.1M Dec/2024
CSL USD 20.55B 3.18B Dec/2024
Pacific Edge NZD 26.08M 14.57M Mar/2025
Paradigm Biopharmaceuticals AUD 34.06M 10.25M Dec/2024
PYC Therapeutics AUD 55.44M 25.62M Dec/2024
Ramsay Health Care AUD 4.81B 82.9M Dec/2024
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Starpharma Holdings AUD 23.17M 4.94M Dec/2024
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024